Bishal Gyawali, Associate Professor at Queen’s University, shared a post on LinkedIn about a paper he authored published in JNCI:
“My new paper is now out in JNCI, where I make a case for why de-escalation trials can be designed as superiority instead of non-inferiority. This allows for a smaller sample size, making de-escalation trials faster, cheaper, and more efficient.”
Title: De-escalation trials do not always need to be noninferiority: a case for superiority design de-escalation trials in oncology
Author: Bishal Gyawali
You can read the Full Article in JNCI: Journal of the National Cancer Institute.
More posts featuring Bishal Gyawali.
